About this Research Topic
The global burden of cancer is on the rise, prompting an urgent need for innovative diagnostic and therapeutic strategies. Recent advancements in molecular technologies have revolutionized our understanding of cancer biology, allowing researchers to delve into the intricate mechanisms of carcinogenesis at the molecular level. Multi-omics approaches, encompassing genomics, epigenomics, transcriptomics, and proteomics, have provided comprehensive insights into the complexities of cancer as a systemic disease.
These advanced technologies have empowered researchers to identify specific molecular signatures associated with various carcinogenic compounds. Furthermore, the development of highly sensitive detection methods for cancer-specific molecular alterations has significantly advanced liquid biopsy techniques and facilitated early cancer detection.
The primary objective of this Research Topic is to serve as a platform for sharing the latest research findings on diverse molecular biomarkers and their applications in cancer detection, diagnosis, and prognosis. Recent breakthroughs in liquid biopsy, single-cell sequencing, and functional genetic association studies using omics technologies have transformed the landscape of cancer management protocols.
This issue aims to highlight specialized areas of cancer research, providing up-to-date insights into the field.
Topics of Interest include, but are not limited to:
• Genomic and Epigenomic Biomarkers of Cancer
• Proteomic and Metabolomic Biomarkers of Cancer
• Single Cell Analysis
• Liquid Biopsy in Cancer Diagnosis
• Transcriptomics in Cancer Research
• Genetic Association Studies in Cancer
• MicroRNA and Non-coding RNA Biomarkers in Cancer
• Immune Biomarkers and Immunotherapy Response Prediction
• Circulating Tumor Cells and Circulating Tumor DNA in Cancer Monitoring
• Metabolic Biomarkers and Metabolic Reprogramming in Cancer
• Tumor Microenvironment Biomarkers and Therapeutic Targeting Strategies
• Cancer and Gender Medicine
These advanced technologies have empowered researchers to identify specific molecular signatures associated with various carcinogenic compounds. Furthermore, the development of highly sensitive detection methods for cancer-specific molecular alterations has significantly advanced liquid biopsy techniques and facilitated early cancer detection.
The primary objective of this Research Topic is to serve as a platform for sharing the latest research findings on diverse molecular biomarkers and their applications in cancer detection, diagnosis, and prognosis. Recent breakthroughs in liquid biopsy, single-cell sequencing, and functional genetic association studies using omics technologies have transformed the landscape of cancer management protocols.
This issue aims to highlight specialized areas of cancer research, providing up-to-date insights into the field.
Topics of Interest include, but are not limited to:
• Genomic and Epigenomic Biomarkers of Cancer
• Proteomic and Metabolomic Biomarkers of Cancer
• Single Cell Analysis
• Liquid Biopsy in Cancer Diagnosis
• Transcriptomics in Cancer Research
• Genetic Association Studies in Cancer
• MicroRNA and Non-coding RNA Biomarkers in Cancer
• Immune Biomarkers and Immunotherapy Response Prediction
• Circulating Tumor Cells and Circulating Tumor DNA in Cancer Monitoring
• Metabolic Biomarkers and Metabolic Reprogramming in Cancer
• Tumor Microenvironment Biomarkers and Therapeutic Targeting Strategies
• Cancer and Gender Medicine
Keywords: liquid biopsy, tumor microenvironment, Cancer Biomarkers, Molecular Diagnostics, Genomic Biomarkers, Proteomics, Single-Cell Sequencing, Epigenomics, Circulating Tumor DNA, MicroRNA
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
